Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus

被引:2
|
作者
Abdaly, Muhammad S. [1 ]
Azizi, Mohamad S. [1 ]
Wijaya, Ika P. [1 ]
Nugroho, Pringgodigdo [1 ]
Purnamasari, Dyah [1 ]
机构
[1] Univ Indonesia, Dept Internal Med, Fac Med, Cipto Mangunkusumo Hosp, Jakarta, Indonesia
关键词
cardiovascular disease; atherosclerosis; first-degree relative; type 2 diabetes mellitus; ANGIOTENSIN-CONVERTING ENZYME; INTIMA-MEDIA THICKNESS; INSULIN-RESISTANCE; FAMILY-HISTORY; GENE POLYMORPHISM; CAROTID-ARTERY; RISK-FACTOR; PREVALENCE; INFLAMMATION; PREDICTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) remain a leading cause of death globally. The concept of acute myocardial infarction in young adults was uncommon. Atherosclerosis is the leading cause of CVD, including myocardial infarction, stroke, heart failure and peripheral artery disease. This condition is initiated early in childhood and progressive in nature. CVD risk factors includes hypertension, dyslipidemia and obesity play a role in the development of atherosclerosis and components in insulin resistance syndrome. One of many risk, factors for insulin resistance in healthy individuals is a first-degree relative (FDR) of Type 2 Diabetes Mellitus (T2DM) patients. This group shows a higher risk of insulin resistance and pancreatic beta cells disruption even in adolescence, although they often remains asymptomatic. Clinical manifestations of metabolic disorders and atherosclerosis will appear earlier in the FDR T2DM group who have sedentary lifestyles and obesity, when compared to the non-FDR group. Several studies have attempted to detect metabolic disorders and sub clinical atherosclerosis that might occur; therefore an early prevention can be carried out in these high-risk groups. Unfortunately, factors that affect the onset and the severity of the prospective clinical manifestations from the previous studies remained inconclusive.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [41] Calcium Phosphate Product Is Associated with Subclinical Carotid Atherosclerosis in Type 2 Diabetes
    Ramirez-Morros, Anna
    Granado-Casas, Minerva
    Alcubierre, Nuria
    Martinez-Alonso, Montserrat
    Real, Jordi
    Castelblanco, Esmeralda
    Esquerda, Aureli
    Cao, Gonzalo
    Rubinat, Esther
    Hernandez, Marta
    Alonso, Nuria
    Fernandez, Elvira
    Mauricio, Didac
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [42] Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
    Mo, Yifei
    Zhou, Jian
    Li, Mei
    Wang, Yuwei
    Bao, Yuqian
    Ma, Xiaojing
    Li, Ding
    Lu, Wei
    Hu, Cheng
    Li, Minghua
    Jia, Weiping
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [43] Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus
    Akbarzadeh, Samad
    Nabipour, Iraj
    Jafari, Seyed Mojtaba
    Movahed, Ali
    Motamed, Niloofar
    Assadi, Majid
    Hajian, Najmeh
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (01) : 132 - 138
  • [44] SOX6 gene polymorphism (rs16933090) and markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus
    Pleskovic, Ales
    Santl Letonja, Marija
    Cokan Vujkovac, Andreja
    Kruzliak, Peter
    Petrovic, Danijel
    INTERNATIONAL ANGIOLOGY, 2016, 35 (06) : 552 - 556
  • [45] Metabolic alteration in healthy men with first degree type 2 diabetic relatives
    Pauer, Jozsef
    Fek, Attila
    Buday, Barbara
    Literati-Nagy, Botond
    Pach, Peter
    Vitai Marta
    Peterfai Eva
    Koranyi Laszlo
    ORVOSI HETILAP, 2013, 154 (05) : 178 - 186
  • [46] The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels
    Akbarzadeh, Samad
    Nabipour, Iraj
    Assadi, Majid
    Movahed, Ali
    Jafari, Seyed Mojtaba
    Motamed, Niloofar
    Nazem, Habibollah
    Haraghy, Mehrnoosh
    Pourbehi, Abdolreza
    Bargahi, Afshar
    Hajian, Najmeh
    CYTOKINE, 2012, 58 (02) : 295 - 299
  • [47] Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease
    Vikulova, Diana N.
    Pinheiro-Muller, Danielle
    Francis, Gordon
    Halperin, Frank
    Sedlak, Tara
    Walley, Keith
    Fordyce, Christopher
    Mancini, G. B. John
    Pimstone, Simon N.
    Brunham, Liam R.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 19
  • [48] The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes
    Karim, R
    Buchanan, TA
    Hodis, HN
    Li, Y
    Mack, WJ
    DIABETIC MEDICINE, 2005, 22 (01) : 81 - 87
  • [49] Association of Sudomotor Dysfunction With Risk of Subclinical Carotid Atherosclerosis in Patients With Type 2 Diabetes
    Wang, Ming
    Lu, Jingyi
    Zhu, Wei
    Ni, Jiaying
    Wang, Yaxin
    Yu, Jiamin
    Zhao, Weijing
    Du, Ronghui
    Zhou, Jian
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2025, 41 (01)
  • [50] Clinical Impact of the Leptin to Soluble Leptin Receptor Ratio on Subclinical Carotid Atherosclerosis in Patients with Type 2 Diabetes
    Yamazaki, Yuko
    Emoto, Masanori
    Morioka, Tomoaki
    Kawano, Naoya
    Lee, Eiko
    Urata, Hiromi
    Tsuchikura, Shoko
    Motoyama, Koka
    Mori, Katsuhito
    Fukumoto, Shinya
    Shoji, Tetsuo
    Nishizawa, Yoshiki
    Inaba, Masaaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2013, 20 (02) : 186 - 194